ELV

NYSE

Elevance Health, Inc.

Health Care, Managed Health Care

$394.20

close 7 Aug 2026

+35.56%

52-week change

$85.48B

market cap

$274.84

$436.24

52-week range

Expected price

$368.82 – $450.78

Current price

$394.20

Signal

Appears fairly valued

A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.

Current multiples

P/E (TTM)17.45x

P/S (TTM)0.43x

P/B1.90x

EV/EBITDA (TTM)—

FCF yield (TTM)7.36%

PEG (TTM, GAAP)13.84

Context

P/E, own 5-year average17.49x

P/E, sector median29.65x*

Price at 5-year median P/E$412.10*

Indicated dividend yield1.75%

Forward — analyst consensus

Forward P/E (FY2026)14.51x*

Forward P/E (FY2027)13.30x

Forward PEG1.59*

Consensus EPS FY2026 (20 analysts)$27.16

EPS growth (FY2026→FY2027)9.12%

Revenue growth (FY2026)-0.68%

Street view

Price target (mean)$449.10*

Target upside13.93%

Ratings (buy / hold / sell)15 / 7 / 0

FY2026 EPS revisions, 30d (up / down)17 / 0

5-year history

Dashed line: average of month-end values

P/E (TTM)

P/S (TTM)

P/B

FCF yield (TTM)

Dividend yield

period to 30 Jun 2026, filed 15 Jul 2026, close 7 Aug 2026

Discounted cash flow

Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.

Free cash flow, last ten years and TTM

5Y CAGR -19.97%10Y CAGR -1.18%

Assumptions

Growth rate, years 1–10%

Perpetual growth%Discount rate%

Base FCF$M

As filed — not assumptions

Current price$394.20

Cash & equivalents$10.23B

Total debt$31.04B

Shares outstanding216.84M

Result

DCF price per share$9.85

Current price$394.20

Margin of safety-97.50%

PV of years 1–10$17.10B

PV of terminal value$5.85B

Equity value$2.14B

Market-implied growth+1.25%

Projected FCF, years 1–10

Hover for PV and growth

Projection detail

Override growth for any year; blank years use the uniform rate

Year	2026	2027	2028	2029	2030	2031	2032	2033	2034	2035	Terminal
Growth, %											2.5
FCF	$5.03B	$4.03B	$3.22B	$2.58B	$2.06B	$1.65B	$1.32B	$1.06B	$846.95M	$677.81M	$12.63B
PV	$4.66B	$3.45B	$2.56B	$1.90B	$1.41B	$1.04B	$771.59M	$571.76M	$423.69M	$313.96M	$5.85B

period to 30 Jun 2026, filed 15 Jul 2026, close 7 Aug 2026